pirfenidone has been researched along with macitentan in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bergmann, C; Distler, JH | 1 |
| Canestaro, WJ; Devine, BE; Forrester, SH; Ho, L; Raghu, G | 1 |
| Behr, J; Bonella, F; Costabel, U; Geißler, K; Günther, A; Koschel, D; Kreuter, M; Müller-Quernheim, J; Prasse, A; Schönfeld, N; Sitter, H | 1 |
| Homma, S; Kabuki, T; Shibuya, K; Sugino, K | 1 |
| Ask, K; Bellaye, PS; Gauldie, J; Granton, E; Hambly, N; Iglarz, M; Imani, J; Kolb, M; Sato, S; Shimbori, C; Upagupta, C; Yanagihara, T | 1 |
| Bai, C; Charalampidis, C; Hohenforst-Schmidt, W; Huang, H; Kosmidis, C; Kougkas, N; Matthaios, D; Nikolaou, C; Oikonomou, P; Papadopoulos, V; Perdikouri, EI; Petanidis, S; Petridis, D; Sardeli, C; Zarogoulidis, P | 1 |
1 review(s) available for pirfenidone and macitentan
| Article | Year |
|---|---|
Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis.
Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Azathioprine; Bayes Theorem; Bosentan; Endothelin Receptor Antagonists; Enzyme Inhibitors; Etanercept; Free Radical Scavengers; Humans; Idiopathic Pulmonary Fibrosis; Imatinib Mesylate; Immunosuppressive Agents; Indoles; Interferon-gamma; Phenylpropionates; Pyridazines; Pyridones; Pyrimidines; Recombinant Proteins; Sulfonamides; Vital Capacity; Warfarin | 2016 |
5 other study(ies) available for pirfenidone and macitentan
| Article | Year |
|---|---|
[Systemic sclerosis - an update].
Topics: Algorithms; Animals; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Endothelin Receptor Antagonists; Guanylate Cyclase; Humans; Hypertension, Pulmonary; Indoles; Pulmonary Artery; Pyrazoles; Pyridones; Pyrimidines; Rituximab; Scleroderma, Systemic; Sulfonamides | 2015 |
German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Antacids; Bosentan; Clinical Trials as Topic; Evidence-Based Medicine; Female; Gastroesophageal Reflux; Guideline Adherence; Humans; Idiopathic Pulmonary Fibrosis; Imatinib Mesylate; Indoles; Male; Middle Aged; Phenylpropionates; Pyridazines; Pyridones; Pyrimidines; Sildenafil Citrate; Sulfonamides | 2018 |
Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension.
Topics: Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Interstitial; Prednisolone; Pulmonary Artery; Pyridones; Pyrimidines; Scleroderma, Limited; Sulfonamides | 2018 |
Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension.
Topics: Animals; Cell Differentiation; Disease Progression; Female; Humans; Hypertension, Pulmonary; Idiopathic Pulmonary Fibrosis; Lung; Male; Myofibroblasts; Pulmonary Fibrosis; Pyridones; Pyrimidines; Rats; Rats, Sprague-Dawley; Sulfonamides; Transforming Growth Factor beta1 | 2018 |
Inhaled nintentanib, pirfenidone and macitentan for pulmonary fibrosis: a laboratory experiment.
Topics: Humans; Nebulizers and Vaporizers; Particle Size; Pulmonary Fibrosis; Respiratory Aerosols and Droplets | 2023 |